5.65
+0.04(+0.71%)
Currency In USD
| Previous Close | 5.61 |
| Open | 5.63 |
| Day High | 5.65 |
| Day Low | 5.62 |
| 52-Week High | 6.28 |
| 52-Week Low | 1.94 |
| Volume | 852,043 |
| Average Volume | 1.12M |
| Market Cap | 301.14M |
| PE | -3.12 |
| EPS | -1.81 |
| Moving Average 50 Days | 5.31 |
| Moving Average 200 Days | 3.79 |
| Change | 0.04 |
If you invested $1000 in scPharmaceuticals Inc. (SCPH) since IPO date, it would be worth $400.71 as of September 28, 2025 at a share price of $5.65. Whereas If you bought $1000 worth of scPharmaceuticals Inc. (SCPH) shares 5 years ago, it would be worth $760.43 as of September 28, 2025 at a share price of $5.65.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
GlobeNewswire Inc.
Aug 25, 2025 11:31 AM GMT
Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for edema due to chronic heart failure and chronic kidney disease, addressing significant unmet needUpfront cash payment of $5.35 per
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
GlobeNewswire Inc.
Aug 14, 2025 12:30 PM GMT
BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, announced today that it ha
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
GlobeNewswire Inc.
Jul 31, 2025 8:01 PM GMT
Management to host conference call and webcast, after-market on August 7, 2025, at 4:30 p.m. ETBURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardior